Obstructive sleep apnea (OSA) is a chronic clinical condition characterized by recurrent apnea or hypopnea during sleep, leading to intermittent hypoxemia, arousal, and sleep fragmentation. OSA affects approximately 9–38 % of the general adult population, including ∼ 13 – 33 % of men and ∼ 6 – 19 % of women, with prevalence rates increasing with age [1]. Snoring, collapse of upper airways, and intermittent hypoxia are the leading causes of inducing chronic systemic inflammation in patients suffering from OSA.
